Objectives To compare infection rates and circulating subtypes of human metapneumovirus
(hMPV) before (2019-2020) and after the emergence of coronavirus disease 2019 (COVID …

Background This study aims to described the epidemiology and genotypic diversity of
Human metapneumovirus (HMPV) and the impact of SARS-CoV-2 on the prevalence of …

Background In the aftermath of the COVID-19 pandemic, there has been a surge in human
metapneumovirus (HMPV) transmission, surpassing pre-epidemic levels. We aim to …

Background Human metapneumovirus (HMPV) is an important aetiologic agent of
respiratory tract infection (RTI). This study aimed to describe the prevalence, genetic …

Human metapneumovirus (HMPV), which is distributed worldwide, is a significant viral
respiratory pathogen responsible for causing acute respiratory tract infections (ARTIs) in …

Human metapneumovirus (hMPV) is a recently discovered respiratory pathogen, infecting
mainly young children. The infected patients suffer from influenza like symptoms (ILS). In …

Background The first outbreak of coronavirus disease 2019 (COVID-19) occurred in March
2020 in Europe, which is normally the peak incidence period of human metapneumovirus …

Objectives Human metapneumovirus (HMPV) is one of the most important respiratory viral
pathogens affecting infants and children worldwide. Our study describes the epidemiological …

Human metapneumovirus (HMPV) infection is one of the leading causes of hospitalization in
young children with acute respiratory illness. In this study, we prospectively collected …

The non-pharmaceutical interventions implemented to prevent the spread of COVID-19 have
affected the epidemiology of other respiratory viruses. In South Korea, Human …